FDA approves Recarbrio for hospital-acquired bacterial pneumonia

Source/Disclosures [1] Disclosures: Nambiar is the director of the division of anti-infectives in the Office of Infectious Disease in FDA’s Center for Drug Evaluation and Research. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Subscribe We were unable...

READ MORE FDA approves Recarbrio for hospital-acquired bacterial pneumonia